VISITOR RESTRICTIONS IN PLACE. Visit link for details and more updates.

Read More

TRAFFIC ALERT: Due to ongoing construction along Central Avenue near Wentworth-Douglass Hospital, anyone traveling to the hospital should be prepared to add additional time to their commute, and for potential detours.

Click to Return
Back Back

Search WDH

Find a Provider

Pathology

Robert R. Cawley, D.O.

Dover, NH 03802

Education & Training

Board Certification

See Profile
Back

Search WDH

Open Clinical Trials

Seacoast Cancer Center

Innovative Research

These clinical trials are currently enrolling new patients.  

Cancer Type/Trial ID

Trial Name

Breast / 
NRG-BR002

Enrollment is currently on hold

Standard of Care Therapy With or Without Stereotactic Radiosurgery and/or Surgery in Treating Patients With Limited Metastatic Breast Cancer

This randomized phase II/III trial studies how well standard of care therapy with stereotactic radiosurgery and/or surgery works and compares it to standard of care therapy alone in treating patients with breast cancer that has spread to one or two locations in the body (limited metastatic) that are previously untreated

Breast / NCT02750826

 Breast Cancer Weight Loss Study (BWEL Study)

This randomized phase III trial studies whether weight loss in overweight and obese women may prevent breast cancer from coming back (recurrence). 

Lung Cancer / ALCHEMIST Trial A151216

Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This research trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

 

Lung Cancer / ALCHEMIST Trial E4512

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

This randomized phase III trial studies how well crizotinib works and compares it to placebo in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK).

COVID-19 / National Cancer Institute

NCI COVID-19 in Cancer Patients, NCCAPS Study

This study collects blood samples, medical information, and medical images from patients who are being treated for cancer and have a positive test for SARS CoV-2, the new coronavirus that causes the disease called COVID-19. Collecting blood samples, medical information, and medical images may help researchers determine how COVID-19 affects the outcomes of patients undergoing cancer treatment and how having cancer affects COVID-19

Pancreatic Cancer / 
Trial A021806

Testing the Use of the Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy drugs, such as fluorouracil, irinotecan, leucovorin, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before and after surgery (perioperatively) may work better in treating patients with pancreatic cancer compared to giving chemotherapy after surgery (adjuvantly).

Contact Us

To schedule, change or get more information about appointments, please contact us at (603) 742-8787.


 

Subscribe to our newsletter.

Sign up to receive occasional emails about Wentworth-Douglass news and events.